SOST and type 2 diabetes mellitus: Our PCa cohort recorded a much higher sclerostin level ranging from 2309.84 (1516.16–4887.19) to 3099.91 (2508.15–7692.70) compared to the levels reported in type 2 diabetes patients28 and haemodialysis patients30 mentioned above.